Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

January 21, 2022

Effectiveness of oral probiotics supplementation in the treatment of adult small chalazion.

International Journal of Ophthalmology
Mariaelena FilippelliCiro Costagliola
January 21, 2022

Prevalence, Risk Factors, Antimicrobial Resistance and Molecular Characterization of Salmonella in Northeast Tunisia Broiler Flocks.

Veterinary Sciences
Walid OueslatiAbdelfettah Ettriqui
January 21, 2022

A combinatorial approach to protect sensory tissue against cisplatin-induced ototoxicity.

Hearing Research
Nicole K FeblesRobert D Frisina
January 20, 2022
Open Access

Potential Clinical Benefits of TDM of Antimicrobials in Japan
Fumiya EbiharaToshimi Kimura
January 20, 2022

Hippo/YAP signaling pathway protects against neomycin-induced hair cell damage in the mouse cochlea.

Cellular and Molecular Life Sciences : CMLS
Maohua WangRenjie Chai
January 19, 2022

Hearing Impairment in South Africa and the Lessons Learned for Planetary Health Genomics: A Systematic Review.

Omics : a Journal of Integrative Biology
Noluthando ManyisaAmbroise Wonkam
January 19, 2022

Nebulized Antibiotics for Healthcare- and Ventilator-Associated Pneumonia.

Seminars in Respiratory and Critical Care Medicine
Matthieu BoissonEuropean Investigator Network for Nebulized Antibiotics in Ventilator-Associated Pneumonia (ENAVAP)
January 19, 2022

Potential for the Development of a New Generation of Aminoglycoside Antibiotics.

Pharmaceutical Chemistry Journal
A N Tevyashova, K S Shapovalova
January 18, 2022

Prednisolone and dexamethasone are systemically absorbed after topical application of ophthalmic suspensions in healthy dogs.

American Journal of Veterinary Research
Margaret M EwaldButch KuKanich
January 18, 2022

Evaluation of penicillin-gentamicin and dual beta-lactam therapies in Enterococcus faecalis infective endocarditis.

International Journal of Antimicrobial Agents
Lauren FreemanNathan Everson
January 17, 2022
Open Access

A qnr-plasmid allows aminoglycosides to induce SOS in Escherichia coli.

Anamaria BabosanThomas Guillard
January 17, 2022
Open Access

Heteroresistance to Amikacin in Carbapenem-Resistant Klebsiella pneumoniae Strains.

Frontiers in Microbiology
Feiyang ZhangYingshun Zhou
January 16, 2022
Open Access

Surveillance of antimicrobial-resistant Escherichia coli in Sheltered dogs in the Kanto Region of Japan.

Scientific Reports
Akihisa HataYasuhiro Yoshikawa

Sign up to follow this feed and discover related papers.

Related Feeds

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Anthelmintics (ASM)

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Ascariasis (ASM)

Ascariasis is a helminthic infection of global distribution with more than 1.4 billion persons infected throughout the world. Here is the latest research.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Bacterial Cell Wall Structure (ASM)

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

© 2022 Meta ULC. All rights reserved